venture
BridgeBio Secures $200 Million from Venture Capitalists to Propel Oncology Spinout Beyond KRAS Class
BridgeBio, venture capital, oncology, spinout, KRAS class, cancer treatment, biotechnology, drug development, investment, healthcare.
Regeneron Launches $500M Venture Fund Led by Former Executives
Regeneron/ venture fund/ $500 million/ biotech/ former executives/ innovation/ investment/ 2024.